As adoption of Continuous Glucose Monitoring (CGM) continues to increase, there is a growing body of evidence supporting the use of this technology in improving diabetes outcomes for patients with type 1 or type 2 diabetes. A new supplement in the journal Diabetes Technology & Therapeutics (DTT) provides an excellent perspective of the past, present, and future of CGM.
from Medical Xpress - latest medical and health news stories https://ift.tt/5aTSjAF
